MAGEL2
Basic information
Region (hg38): 15:23643549-23647867
Previous symbols: [ "NDNL1" ]
Links
Phenotypes
GenCC
Source:
- Schaaf-Yang syndrome (Definitive), mode of inheritance: Autosomal dominant inheritance with maternal imprinting HP:0012275
- Schaaf-Yang syndrome (Strong), mode of inheritance: AD
- Schaaf-Yang syndrome (Definitive), mode of inheritance: AD
- Schaaf-Yang syndrome (Definitive), mode of inheritance: AD
- Schaaf-Yang syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Schaaf-Yang syndrome (Prader-Willi-like syndrome) | AD | Endocrine | The condition has been described as including neonatal hyperinsulinemia hypoglycemia, and awareness may allow prompt management | Craniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic | 24076603; 25473036; 26365340; 27195816; 28281571 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (20 variants)
- Schaaf-Yang syndrome (16 variants)
- Inborn genetic diseases (5 variants)
- Prader-Willi syndrome (2 variants)
- Generalized hypotonia;Ventriculomegaly;Multiple joint contractures;Ambiguous genitalia (1 variants)
- Schaaf-Yang syndrome;Prader-Willi-like syndrome (1 variants)
- Developmental disorder (1 variants)
- Neurodevelopmental disorder (1 variants)
- Neurodevelopmental delay (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAGEL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 33 | 163 | 11 | 207 | ||
missense | 450 | 43 | 501 | |||
nonsense | 14 | 11 | 28 | |||
start loss | 1 | |||||
frameshift | 22 | 18 | 43 | |||
inframe indel | 41 | 47 | ||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 37 | 30 | 531 | 212 | 20 |
Variants in MAGEL2
This is a list of pathogenic ClinVar variants found in the MAGEL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-23643744-A-T | Benign (Jul 09, 2018) | |||
15-23643886-G-T | Benign (Jul 09, 2018) | |||
15-23643995-A-T | Uncertain significance (Apr 01, 2023) | |||
15-23643997-C-T | MAGEL2-related disorder | Conflicting classifications of pathogenicity (Aug 28, 2023) | ||
15-23643998-G-A | Uncertain significance (Jun 15, 2023) | |||
15-23643998-G-C | Uncertain significance (Jul 26, 2023) | |||
15-23644003-G-A | Uncertain significance (Jan 03, 2023) | |||
15-23644004-G-C | Inborn genetic diseases | Uncertain significance (Aug 28, 2023) | ||
15-23644015-G-A | Uncertain significance (Dec 05, 2022) | |||
15-23644016-T-C | Schaaf-Yang syndrome | Uncertain significance (Aug 01, 2022) | ||
15-23644020-G-T | Uncertain significance (May 08, 2023) | |||
15-23644022-C-T | Benign/Likely benign (Nov 24, 2023) | |||
15-23644023-G-T | Schaaf-Yang syndrome | Uncertain significance (Feb 14, 2023) | ||
15-23644026-G-T | Likely benign (Jun 04, 2022) | |||
15-23644030-C-T | MAGEL2-related disorder | Uncertain significance (May 21, 2024) | ||
15-23644037-C-T | MAGEL2-related disorder | Uncertain significance (Dec 11, 2023) | ||
15-23644038-G-C | Likely benign (Apr 18, 2022) | |||
15-23644039-G-T | MAGEL2-related disorder | Uncertain significance (Oct 16, 2022) | ||
15-23644040-T-G | Inborn genetic diseases | Uncertain significance (Jun 16, 2024) | ||
15-23644041-G-GTCA | MAGEL2-related disorder | Uncertain significance (Sep 04, 2024) | ||
15-23644049-C-T | MAGEL2-related disorder | Uncertain significance (Mar 12, 2024) | ||
15-23644053-C-G | not specified | Conflicting classifications of pathogenicity (Feb 01, 2024) | ||
15-23644060-G-A | Uncertain significance (Jul 22, 2021) | |||
15-23644067-C-G | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
15-23644072-T-C | Uncertain significance (Sep 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAGEL2 | protein_coding | protein_coding | ENST00000532292 | 1 | 2485 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.975 | 0.0249 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.563 | 399 | 369 | 1.08 | 0.0000209 | 4145 |
Missense in Polyphen | 76 | 73.131 | 1.0392 | 861 | ||
Synonymous | -1.72 | 185 | 158 | 1.17 | 0.00000941 | 1352 |
Loss of Function | 3.75 | 2 | 20.2 | 0.0992 | 0.00000112 | 209 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probably enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, possibly through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Acts as a regulator of retrograde transport via its interaction with VPS35. Recruited to retromer-containing endosomes and promotes the formation of 'Lys- 63'-linked polyubiquitin chains at 'Lys-220' of WASHC1 together with TRIM27, leading to promote endosomal F-actin assembly (PubMed:23452853). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Significantly promotes the cytoplasmic accumulation of CLOCK (By similarity). {ECO:0000250|UniProtKB:Q9QZ04, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:23452853}.;
- Pathway
- Circadian rythm related genes;Prader-Willi and Angelman Syndrome
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.293
- ghis
- 0.463
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Magel2
- Phenotype
- muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; taste/olfaction phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- Arp2/3 complex-mediated actin nucleation;retrograde transport, endosome to Golgi;regulation of circadian rhythm;negative regulation of transcription, DNA-templated;rhythmic process;protein K63-linked ubiquitination
- Cellular component
- nucleus;endosome;early endosome;cytosol;retromer complex
- Molecular function
- ubiquitin-protein transferase activity;protein binding